NCT05131451View on ClinicalTrials.gov

ACCESS: AI for pediatriC diabetiC Eye examS Study

NACompletedINTERVENTIONAL

Enrollment

164

Participants

Timeline

Start Date

November 24, 2021

Primary Completion Date

December 6, 2022

Study Completion Date

December 31, 2022

Conditions

Type 1 DiabetesType 2 Diabetes

Interventions

DIAGNOSTIC_TEST

Point of Care Autonomous AI diabetic retinopathy exam

Participants will get a point of care diabetic retinopathy eye exam using autonomous AI. Those that test positive will be referred to Eye Care Provider for dilated eye exam.

Trial Locations (1)

21287

Johns Hopkins Pediatric Diabetes Center, Baltimore

All Listed Sponsors

collaborator

National Eye Institute (NEI)

NIH

lead

Johns Hopkins University

OTHER

NCT05131451 - ACCESS: AI for pediatriC diabetiC Eye examS Study | Biotech Hunter | Biotech Hunter